Literature DB >> 12446193

Could procalcitonin be a predictive biological marker in systemic fungal infections?. Study of 14 cases.

Sofia Christofilopoulou1, Ekatherina Charvalos, George Petrikkos.   

Abstract

BACKGROUND: Procalcitonin (PCT) is a recently described inflammatory marker that has been shown to increase significantly in patients with severe systemic bacterial infections or sepsis. Reports on the diagnostic and predictive value of PCT in systemic fungal infections are limited.
METHODS: In order to evaluate the role of PCT in systemic mycosis, 14 patients (mean age 40 years) with proven or probable systemic fungal infections were investigated. Blood samples were collected on days 1, 3, 5, and 10 after the onset of signs and symptoms of systemic fungal infection (clinical and/or laboratory diagnosis and/or radiographic evidence). PCT measurements were performed using an immunoluminometric assay.
RESULTS: In five patients with severe fungal infection and an unfavorable course (patient group 2), PCT levels were moderately elevated on day 3 (0.5-1.0 ng/ml), whereas they were normal in the patients who recovered (patient group 1). High PCT levels (>/=1.11 ng/ml) were detected on the 10th day of the course of the illness in patient group 2. A normal or moderate elevation of PCT on day 10 was observed in patient group 1. The difference in mean PCT levels in patient groups 1 and 2 on days 3 and 10 were statistically significant.
CONCLUSIONS: PCT levels seem to correlate with the severity and outcome of systemic fungal infection. If this finding can be confirmed in a larger number of patients, it could serve as a prognostic indicator.

Entities:  

Year:  2002        PMID: 12446193     DOI: 10.1016/s0953-6205(02)00160-7

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  12 in total

1.  Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections.

Authors:  G L Petrikkos; S A Christofilopoulou; N K Tentolouris; E A Charvalos; C J Kosmidis; G L Daikos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

2.  Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.

Authors:  Pierre Emmanuel Charles; Frédéric Dalle; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Hervé Aube; Nils-Olivier Olsson; Bernard Blettery
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

3.  Procalcitonin--a marker of invasive fungal infection?

Authors:  H J Dornbusch; V Strenger; R Kerbl; H Lackner; W Schwinger; P Sovinz; C Urban
Journal:  Support Care Cancer       Date:  2005-01-19       Impact factor: 3.603

4.  The role of procalcitonin in neonatal intensive care unit patients with candidemia.

Authors:  Maria Teresa Montagna; Caterina Coretti; Antonella Rella; Giovanna Barbuti; Fabio Manca; Osvaldo Montagna; Nicola Laforgia; Giuseppina Caggiano
Journal:  Folia Microbiol (Praha)       Date:  2012-06-12       Impact factor: 2.099

5.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

6.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.

Authors:  Markéta Marková; Helena Brodská; Karin Malíčková; Veronika Válková; Petr Cetkovský; Michal Kolář; Martin Haluzík
Journal:  Support Care Cancer       Date:  2013-05-28       Impact factor: 3.603

7.  Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis?

Authors:  Pierre Emmanuel Charles; Carmen Castro; Sergio Ruiz-Santana; Cristóbal León; Pedro Saavedra; Estrella Martín
Journal:  Intensive Care Med       Date:  2009-09-16       Impact factor: 17.440

8.  Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?

Authors:  James Owen Robinson; Frédéric Lamoth; Frank Bally; Marlies Knaup; Thierry Calandra; Oscar Marchetti
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

9.  Procalcitonin and quantitative C-reactive protein role in the early diagnosis of sepsis in patients with febrile neutropenia.

Authors:  Mohsen Meidani; Farzin Khorvash; Hojat Abolghasemi; Bahareh Jamali
Journal:  South Asian J Cancer       Date:  2013-10

Review 10.  [Cancer patients in operative intensive care medicine].

Authors:  T Annecke; A Hohn; B Böll; M Kochanek
Journal:  Anaesthesist       Date:  2018-02       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.